Literature DB >> 21946050

Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.

Marianne Canonico, Pierre-Yves Scarabin.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21946050      PMCID： PMC4921123          DOI： 10.1097/gme.0b013e31822d6677

Source DB:  PubMed          Journal:  Menopause        ISSN： 1072-3714            Impact factor:   2.953


× No keyword cloud information.
  16 in total

1.  Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Authors:  Wulf H Utian; David F Archer; Gloria A Bachmann; Christopher Gallagher; Francine n Grodstein; Julia R Heiman; Victor W Henderson; Howard N Hodis; Richard H Karas; Rogerio A Lobo; JoAnn E Manson; Robert L Reid; Peter J Schmidt; Cynthia A Stuenkel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

2.  Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.

Authors:  Christel Renoux; Sophie Dell'aniello; Edeltraut Garbe; Samy Suissa
Journal:  BMJ       Date:  2010-06-03

3.  Hormone replacement therapy and the risk of venous thromboembolism: a population-based study.

Authors:  C Renoux; S Dell'Aniello; S Suissa
Journal:  J Thromb Haemost       Date:  2010-03-04       Impact factor: 5.824

4.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

5.  Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Authors:  Marianne Canonico; Emmanuel Oger; Geneviève Plu-Bureau; Jacqueline Conard; Guy Meyer; Hervé Lévesque; Nathalie Trillot; Marie-Thérèse Barrellier; Denis Wahl; Joseph Emmerich; Pierre-Yves Scarabin
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

Review 6.  Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.

Authors:  Valérie Olié; Marianne Canonico; Pierre-Yves Scarabin
Journal:  Curr Opin Hematol       Date:  2010-09       Impact factor: 3.284

7.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

8.  Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.

Authors:  Marianne Canonico; Agnès Fournier; Laure Carcaillon; Valérie Olié; Geneviève Plu-Bureau; Emmanuel Oger; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Pierre-Yves Scarabin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-15       Impact factor: 8.311

9.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

10.  Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.

Authors:  François Laliberté; Katherine Dea; Mei Sheng Duh; Kristijan H Kahler; Melanie Rolli; Patrick Lefebvre
Journal:  Menopause       Date:  2011-10       Impact factor: 3.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.